BLUE BIOFUELS, INC. (BIOF) Financial Statements (2024 and earlier)

Company Profile

Business Address 3710 BUCKEYE ST
PALM BEACH GARDENS, FL 33401
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 286 - Industrial Organic Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments61,677163,123211,901505,010628,906620,260
Cash and cash equivalents61,677163,123211,901505,010628,906620,260
Receivables      
Prepaid expense61,11861,11843,11986,780111,94782,889
Total current assets:122,795224,241255,020591,790740,853703,149
Noncurrent Assets
Operating lease, right-of-use asset129,745154,072178,399167,15826,34146,097
Property, plant and equipment642,100671,942420,115359,439311,334363,937
Intangible assets, net (including goodwill)234,730234,730222,109197,259173,030173,030
Intangible assets, net (excluding goodwill)234,730234,730222,109197,259173,030173,030
Other undisclosed noncurrent assets30,27630,27630,27630,27630,27630,276
Total noncurrent assets:1,036,8511,091,020850,899754,132540,981613,340
TOTAL ASSETS:1,159,6461,315,2611,105,9191,345,9221,281,8341,316,489
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities102,71882,849113,273152,596129,428131,462
Interest and dividends payable69,42662,71456,003
Accounts payable   37,13513,7444,00019,456
Accrued liabilities102,71882,84976,13869,42662,71456,003
Debt350,000250,00050,00050,00050,00050,000
Due to related parties380,276373,776366,276443,804
Other undisclosed current liabilities825,107534,35395,17222,685(33,342)(4,983)
Total current liabilities:1,277,825867,202638,721599,057512,362620,283
Noncurrent Liabilities
Long-term debt and lease obligation216,570216,570216,570327,267216,570216,570
Long-term debt, excluding current maturities216,570216,570216,570216,570216,570216,570
Finance lease, liability    110,697  
Liabilities, other than long-term debt34,90960,6372,607,5452,521,5622,521,5622,521,562
Due to related parties2,521,5622,521,5622,521,5622,521,562
Operating lease, liability34,90960,63785,983   
Other undisclosed noncurrent liabilities2,721,5622,521,562    
Total noncurrent liabilities:2,973,0412,798,7692,824,1152,848,8292,738,1322,738,132
Total liabilities:4,250,8663,665,9713,462,8363,447,8863,250,4943,358,415
Equity
Equity, attributable to parent, including:(3,091,221)(2,350,710)(2,356,917)(2,101,964)(1,968,660)(2,041,926)
Common stock300,584299,417289,942281,817279,381274,602
Additional paid in capital51,608,07051,195,54950,134,72749,822,66249,339,70948,545,832
Accumulated deficit(54,999,875)(53,845,676)(52,781,586)(52,206,443)(51,587,750)(50,862,360)
Other undisclosed equity, attributable to parent      
Other undisclosed equity 1     
Total equity:(3,091,220)(2,350,710)(2,356,917)(2,101,964)(1,968,660)(2,041,926)
TOTAL LIABILITIES AND EQUITY:1,159,6461,315,2611,105,9191,345,9221,281,8341,316,489

Income Statement (P&L) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Operating expenses(1,118,038)(1,054,776)(598,305)(582,669)(718,086)(2,033,216)
Operating loss:(1,118,038)(1,054,776)(598,305)(582,669)(718,086)(2,033,216)
Nonoperating income (expense)(36,161)(9,314)23,162(36,024)(7,304)(7,741)
Interest and debt expense(2,378)(2,602)28,374(29,313)(592)(1,029)
Loss from continuing operations before income taxes:(1,156,577)(1,066,692)(546,769)(648,006)(725,982)(2,041,986)
Other undisclosed income (loss) from continuing operations2,3782,602(28,374)29,3135921,029
Loss from continuing operations:(1,154,199)(1,064,090)(575,143)(618,693)(725,390)(2,040,957)
Loss before gain (loss) on sale of properties:(618,693)(725,390)(2,040,957)
Net loss available to common stockholders, diluted:(1,154,199)(1,064,090)(575,143)(618,693)(725,390)(2,040,957)

Comprehensive Income (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(1,154,199)(1,064,090)(575,143)(618,693)(725,390)(2,040,957)
Comprehensive loss, net of tax, attributable to parent:(1,154,199)(1,064,090)(575,143)(618,693)(725,390)(2,040,957)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: